Professional and Business Ethics in Health Care

Slides:



Advertisements
Similar presentations
Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.
Advertisements

Integrity and impartiality
MEDICINES SELECTION & FORMULARY MANAGEMENT
Sizewise Code of Ethics, Conflict of Interest and Disclosure HR-CECID.
Presented to CSO workshops in Kabwe on 18 July 2014, Livingstone on 28 July 2014 and Lusaka on 27 August 2014.
The AMA Code of Ethics Could Egyptian Marketing Professionals Agree on a List of Rules, Perhaps Similar to This? The IMI Journal. Members of the AMA are.
Stockouts: The legal framework Sasha Stevenson 25 July 2013.
Lecture 9 Tuesday, October 2 Healthcare and the Market.
Ethics: The Key Component to Health Care Organizations William Nelson, PhD June 1, 2010 International Hospital Federation.
Business-Ethics Issues in the Healthcare Industry in the U.S. (Ethics of the Business of Medicine)
HSA 171 CAR. Health care Systems 1436/ 6/30  The Means by Which Societies Provide Support for Citizens to Maintain Their Good Health 3.
Conflicts of Interest James G. Anderson, Ph.D. Department of Sociology & Anthropology.
Business ethics chapter one
What is Strategy? (Part Two). Key Concepts Managerial Cognition Business Model Stakeholders The Balanced Scorecard.
MZC1© 2005 by Lippincott Williams & Wilkins Unit I: Foundations of Community Health Chapter 7 Economics of Health Care.
©2003 Prentice Hall Business Publishing, Auditing and Assurance Services 9/e, Arens/Elder/Beasley Professional Ethics Chapter 4.
PART FOUR – COMMERCIAL LEGISLATION in the UAE
[Hospital Name | Presenter name and title | Date of presentation]
Towards an Integrity Standard in the Pharmaceutical Industry IACC Conference, May 27, 2003 Seoul, Korea Dr. Jillian Clare Cohen Assistant Professor, Leslie.
Year 11 R and S Ethics Great Ethical Thinkers. Codes of Ethics in Society.
Community Level Models; Participatory Research and Challenges
Part 2  In community-based long-term care, the resident may simply need assistance with taking their medications at the right time or with preparing.
Control environment and control activities. Day II Session III and IV.
Human Resource Management Gaining a Competitive Advantage
GSU-NACDD-CDC Chronic Disease and Public Health Workforce Training Training Needs Survey and Public Health Certificate in Chronic Disease Training for.
Strategic Human Resource Management
Ethics & Social Responsibility
C H A P T E R 2 Stakeholder Relationships, Social Responsibility, and Corporate Governance.
Ethics and Social Responsibility
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
Right Drug, Right Person, Right Price: Improving and Governing the Provincial Drug System Helen Stevenson Executive Lead, Drug System Secretariat Ministry.
1 Professionalism and Accountability Joy Wingfield Short residential course Session 4 September 11th 2006.
Stakeholders and Ethics Organizational Stakeholders Stakeholders: people who have an interest, claim, or stake in an organization  Inside stakeholders.
Marketing Ethics and Social Responsibility
Respect and Advocacy Sabato A. Stile M.D.. Worldwide, Complex, Public Health Problem affects people from all demographic and social groups and economic.
Ethical & legal of professional organization Outline Definition of profession. Characteristics of profession. Code of Ethical Principles and Standards.
Patient, health care and pharmaceutical promotion – a critical inventory Hans-Joachim Both Neurologist, member of IPPNW group Berlin mail adress :
Summary of ICIUM Chronic Care Track Prepared by: Ricardo Perez-Cuevas Veronika Wirtz David Beran.
+ Conflict of Interest in Physician-Industry Relationships.
Crosswalk of Public Health Accreditation and the Public Health Code of Ethics Highlighted items relate to the Water Supply case studied discussed in the.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
D.Zucker Draft-EB09 Ethics & Academic Technology Transfer: Patients, Products and Public Trust Deborah Zucker, MD, PhD, Tufts Medical Center.
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
Copyright © Houghton Mifflin Company. All rights reserved.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
+ Role of Industry in Clinical Care, Research, and Education.
Schermerhorn - Chapter 41 Chapter 4 Ethical Behavior and Social Responsibility 4 Planning Ahead –What is ethical behavior? –How do ethical dilemmas complicate.
INSTRUCTOR'S MANUAL Chapter 3 ESTABLISHING A BUSINESS.
1.4 Stakeholders. Stakeholders Not to be confused with Shareholders. Shareholders own a share in the company. Stakeholder is anyone with an interest in.
Sara Lovell, CPCS Education Coordinator Providence Alaska Medical Center.
Chapter 2: The Role of Economics
Ethics Case 1 Remonte. Rivera, K., Sagayaga. Siy. Talan.
Single Competency Framework for Prescribers National Prescribing Centre (2012)
Development Planning & Administration MPA – 403 Lecture-10 FACILITATOR Prof. Dr. Mohammad Majid Mahmood Bagram ,
Health Economics & “The Future World of Health Care” Thomas S. Campanella, MA, JD Professor of Health Economics Baldwin Wallace University Of-counsel,
1-1 Human Resource Management: Gaining a Competitive Advantage HRM.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
Pharmaceutical Society of Ireland – The Pharmacy Regulator The Role of the Pharmacist in Self Care Telephone: Shrewsbury Rd Fax:
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
3 - 1 ©2003 Prentice Hall Business Publishing, Essentials of Auditing 1/e, Arens/Elder/Beasley Professional Ethics Chapter 3.
CORPORATE SOCIAL RESPONSIBILITY. CORPORATE SOCIAL RESPONSIBILITY (CSR) CSR is concerned with treating the stakeholders of the firm ethically or in a responsible.
An Economic Perspective
Convening today at TIFR, Mumbai on 29th January, 2017, on the occasion of the Tata Memorial Centre Platinum Jubilee Conference – ‘Healthcare – a commodity.
Ethics & Social Responsibility
44 Nursing: A Concept-Based Approach to Learning Ethics MODULE
Ethics & Social Responsibility
AGREEMENT FOR TRANSPARENCY The Case of Mexico
Business Ethics.
Differentiate between ethical and legal issues impacting health care.
Presentation transcript:

Professional and Business Ethics in Health Care dr. Nur Azid Mahardinata Center for Bioethics and Medical Humanities Faculty of Medicine, Universitas Gadjah Mada

HOW CAN WE EXPLAIN THIS PHENOMENA? Background Medical professional is facing a decreasing professionalism and increasing ethical problems around the globe Charles Dougherty: “General features of the pervasive hold of commercialism in medicine include an increase in competition and decline in professionalism among physicians, a view of health care as commodity and patients as consumers, and a general depersonalization of doctor-patient relationship including dilution of the tradition of physician as patient advocate” HOW CAN WE EXPLAIN THIS PHENOMENA?

FIRST: The Theory of Market Developed by Adam Smith: Economic man, self-interested, and fundamentally asocial, motivated by an insatiable desire to improve his material condition, is the model that explains human motivation and action The special characteristics of healthcare market is both Private as well as Social/Public domain Therefore, health care business is unique. It must balance the obligation to care for others with the necessity of making a profit as a business.

Pharmaceutical Industry Patient Care Profit Making Hospital Pharmaceutical Industry Physician Government Patient and Families

What is profitable to Businesses in the Healthcare industry: Selling Medicine/Drugs Selling Medical Supplies Hospital equipment Lab equipment Selling Medical Services Patient care Nursing home care Home care New Health Care Technology

Market Driven Care Advantage Disadvantage Incentive for innovation Incentive for efficiency Less government intervention Alienate physicians Undermine patient trust of physicians Hurt academic medical centers and the research establishment More patients without health care coverage.

Public Cost of Poor Health Higher disease burden Longer time to recover from sickness Shorter time to work (become productive – economically and socially) Lower life expectancy

What is not as directly profitable is: Prevention “An ounce of prevention is worth a pound of cure” But companies can’t make much money from preventing diseases Therefore, healthcare should be managed by the “people” and “for the people”

How Market Driven Healthcare Cuts Costs recruit the healthiest patients excluding the sickest rationing care by making it inconvenient to obtain denying care by a variety of mechanisms.

Physicians’ Dilemma in Market Driven Healthcare As Caregiver: provide a wide range of services, recommend the best treatments improve patients' quality of life As Efficiently keeping expenses to a minimum: limit the use of services increase efficiency shorten the time spent with each patient use specialists sparingly

Managed healthcare plans Good of Patient vs ….. (1) the good of all the other patients served by the plan (2) the good of the plan and the organization themselves (3) the self-interest of the physician. from Edmund Pellegrino

Second: Stakeholder Theory: Who are the Stakeholders for a Healthcare Organization?

From Pat Werhane: “Business Ethics, Stakeholder Theory, and the Ethics of Healthcare in Organizations”

The Investor: Pharmaceutical Industries The pharmaceutical industry in 2006 was worth US$ 643 billion. Total pharmaceutical sales from the top 10 companies accounted for more than 40% of the total market (see table).

Pharmaceutical Industry as Investors Irrational Use of Drugs In 2005, the Indian National Commission on Macroeconomics and Health labeled 10 out of 25 top selling brands of medicines in the country as being either “irrational or non-essential or hazardous.”

Pharmaceutical Industry as Investors Questionable New Drugs A survey in April 2005 by the French journal La Revue Prescribe concluded that 68 per cent of the 3,096 new products approved in France between 1981 and 2004 brought “nothing new” to existing treatments. A breakdown of more than 1,000 new drugs approved by the US Food and Drug Administration between 1989 and 2000 revealed that more than three-quarters had no therapeutic benefit over existing products.

Pharmaceutical Industry as Investors Advertising with Incomplete Information 2005 study of Psychobiology of the Paulista Medical School of the Federal University of São Paulo Brazil Analysed 24 Brazilian advertisements for the same psychoactive drugs as advertised in American and/or British publications from the same period. Observed that “Brazilian advertisements omitted information on usage restrictions, such as contraindications, adverse reactions, interactions, warnings and precautions, and that such information was present in American and British advertisements.”

How They Do It? --- Drug Promotion is the Key Increasing the perceived frequency and/or severity of the indications. 2. Widening the indications to include more people. 3. Increasing the perceived likelihood and magnitude of benefits. 4. Decreasing the perceived likelihood and magnitude of harms. 5. Increasing the use of the drug for longer durations.

Pharmaceutical Gifts in Pakistan • Low cost: pens/pads/diaries/calendars. Medium cost: stethoscope/books/briefcases. High cost: air conditioners/laptops/desktop computers/club membership. The latest practice is: For writing 200 prescriptions of the company’s high priced drug, a doctor is rewarded with the down payment on a brand new car. What about in Indonesia??

Doctors’ Biased Behavior Evidence shows that biased doctors are more likely to: Prescribe a drug if they had recently attended a sponsored event by the manufacturer. Prescribe a drug that is not clinically indicated. Have a drug placed on a hospital formulary.

*Governments’ Key Recommendations: Implement, improve and monitor legislation in line with the WHO Resolution on the Rational Use of Medicines and the WHO Ethical Criteria for Medicinal Drug Promotion. Support the provision of independent information on drugs for consumers and health professionals. Implement and enforce a ban on gifts to doctors. Enforce strict sanctions that will deter poor corporate practice in drug promotion. Take measures to improve the transparency of drug companies’ marketing activities and seriously address the conflict of interest encountered in drug companies’ funding of medical education.

**Key Recommendations at the Company Level: 1. Stop the practice of gifts to doctors 2. Implement rigorous policies on vetting of drug promotion materials and adherence to existing codes of conduct 3. Provide transparent and verifiable information on the precise nature of relationships and associated funding for all stakeholder groups, including health professionals, pharmacists, students, journalists, clinical research organizations and patient groups.

**Industry-Wide Level: 1. Ensure codes of conduct on drug promotion extend to interactions with health professionals AND consumers. 2. Invest in innovative partnerships with government and civil society organizations so that corporate funding of disease awareness campaigns, and CME may be channeled via blind trusts in line with specific health priorities of consumers at a community or national level.

Bibliography Drugs, Doctors and Dinners: How drug companies influence health in the developing world Managed Care and the Morality of the Marketplace (NEJM, 333:50-52, 7/6, 1995)

How to maintain the humanitarian aspects of health care? Professionalism and ethics are the key to maintain humanitarian aspects of health care

How to Execute Ethical Principles in an Organization? Organizational Goals Approach The Stakeholder Analysis Approach Ethical Justifiable Decision

Organizational Goals Approach Institutional mission statements are commonly expressed the development and implementation of organizational goals An ethical analysis of organization behavior can be conceived as a means of ensuring that an appropriate mission statement is adopted, kept up date, and put into effect The J&J case (1982) – “a 350 words credo” “First, responsibility of the company is to healthcare professionals and customers who use its products”

Useless mission statement: “To improve the total health of our communities, working in partnership with the people we serve” A hospital has ethical responsibilities deriving from its organizational roles as employer and business entity Institution Its physician Other care givers Employers Individual patients and families Community as a whole

The Woodstock Ethical Framework Compassion and respect for human dignity Commitment to professional competence Commitment to a spirit of service Honesty Confidentiality Good stewardship and careful administration

Model Hospital Mission Statement (1) It is the goal and mission of general hospital to: Offer care to all without regard to race, religion, or ethnic identity and to the extent that resources permit, irrespective of the ability to pay Offer health and wellness programs and health education to the people of our service area Provide the best available medical care to our patients honoring their rights to determine the course their treatment

Model Hospital Mission Statement (2) Employ open and ethical business practices in our dealings with patients, professional associates, allied service providers and business partners Provide a fulfilling place of employment to our professional staff and employees including appropriate compensation, healthful working conditions, and opportunities for education and advancement Use the resources provided by benefactors, foundations, and public entities as efficiently as possible in the pursuit of these goals

Stakeholder Analysis “Any group or individual who can affect or is affected by the corporation” (Evan and Freeman, 1988:100) Primary stakeholders: groups whose continued participation is necessary to the survival of the organization (e.g. shareholders, employees, customers, suppliers, creditors, and governments) Secondary stakeholders: groups whose participation is not essential to the organization, although they are affected by organizational activities (e.g. media, community, and other business)

Remember the Formula Organizational Goals Approach The Stakeholder Analysis Approach Ethical Justifiable Decision

Thank You for your kind attention